Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting

about

Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting

Item

http://www.wikidata.org/entity/Q58804808

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Neurohormonal modulation as th ...... ension: till the dawn, waiting

@en

Neurohormonal modulation as th ...... ension: till the dawn, waiting

@nl

type

Item

label

Neurohormonal modulation as th ...... ension: till the dawn, waiting

@en

Neurohormonal modulation as th ...... ension: till the dawn, waiting

@nl

prefLabel

Neurohormonal modulation as th ...... ension: till the dawn, waiting

@en

Neurohormonal modulation as th ...... ension: till the dawn, waiting

@nl

P1476

Neurohormonal modulation as th ...... ension: till the dawn, waiting

@en

P2093

Abhishek Jaiswal

http://www.w3.org/2001/XMLSchema#string

Astha Chichra

http://www.w3.org/2001/XMLSchema#string

Nirav Patel

http://www.w3.org/2001/XMLSchema#string

Roy Emanuel

http://www.w3.org/2001/XMLSchema#string

Thierry H Le Jemtel

http://www.w3.org/2001/XMLSchema#string

P2860

The adrenergic system in pulmonary arterial hypertension: bench to bedside (2013 Grover Conference series)

Non-pharmacological modulation of the autonomic tone to treat heart failure

Management of pulmonary arterial hypertension

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

Alpha1-adrenergic hypothesis for pulmonary hypertension.

beta-adrenergic receptor blockade in chronic heart failure.

ACE2 improves right ventricular function in a pressure overload model.

Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.

Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.

Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension.

P304

301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/ATM.2018.06.04

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30211189

http://www.w3.org/2001/XMLSchema#string

P932

6123204

http://www.w3.org/2001/XMLSchema#string